000 01386 a2200373 4500
005 20250513075012.0
264 0 _c19930923
008 199309s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1993.tb22916.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSher, E
245 0 0 _aNeuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJun 1993
300 _a373-81 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibody Specificity
650 0 4 _aAutoantibodies
_ximmunology
650 0 4 _aCalcium Channels
_xdrug effects
650 0 4 _aCarcinoma, Small Cell
_ximmunology
650 0 4 _aCell Line
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aLambert-Eaton Myasthenic Syndrome
_ximmunology
650 0 4 _aLung Neoplasms
_ximmunology
650 0 4 _aNerve Tissue Proteins
_xphysiology
650 0 4 _aNeurons
_ximmunology
650 0 4 _aPeptides
_xpharmacology
650 0 4 _aomega-Conotoxin GVIA
700 1 _aCarbone, E
700 1 _aClementi, F
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 681
_gp. 373-81
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1993.tb22916.x
_zAvailable from publisher's website
999 _c8394423
_d8394423